RAF dimer inhibition enhances the antitumor activity of MEK inhibitors in K‐RAS mutant tumors

The mutation of K‐RAS represents one of the most frequent genetic alterations in cancer. Targeting of downstream effectors of RAS, including of MEK and ERK, has limited clinical success in cancer patients with K‐RAS mutations. The reduced sensitivity of K‐RAS‐mutated cells to certain MEK inhibitors...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Oncol
Main Authors: Yuan, Xi, Tang, Zhiyu, Du, Rong, Yao, Zhan, Cheung, Shing‐Hu, Zhang, Xinwen, Wei, Jing, Zhao, Yuan, Du, Yunguang, Liu, Ye, Hu, Xiaoxia, Gong, Wenfeng, Liu, Yong, Gao, Yajuan, Huang, Zhiyue, Cao, Zongfu, Wei, Min, Zhou, Changyou, Wang, Lai, Rosen, Neal, Smith, Paul D., Luo, Lusong
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Research Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7400788/
https://ncbi.nlm.nih.gov/pubmed/32336014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12698
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker